Human iPS cell-engineered cardiac tissue sheets with cardiomyocytes and vascular cells for cardiac regeneration. - Wikidata - wikimedia - TriplyDB

Human iPS cell-engineered cardiac tissue sheets with cardiomyocytes and vascular cells for cardiac regeneration.

Human iPS cell-engineered cardiac tissue sheets with cardiomyocytes and vascular cells for cardiac regeneration.

http://www.wikidata.org/entity/Q30594949

about

Cell Therapy in Ischemic Heart Disease: Interventions That Modulate Cardiac Regeneration From cardiac tissue engineering to heart-on-a-chip: beating challenges Simulated Microgravity and 3D Culture Enhance Induction, Viability, Proliferation and Differentiation of Cardiac Progenitors from Human Pluripotent Stem Cells The myocardial regenerative potential of three-dimensional engineered cardiac tissues composed of multiple human iPS cell-derived cardiovascular cell lineages.A Systemized Approach to Investigate Ca(2+) Synchronization in Clusters of Human Induced Pluripotent Stem-Cell Derived Cardiomyocytes Therapeutic Potential of Stem Cells Strategy for Cardiovascular Diseases Human iPS Cell-Derived Cardiac Tissue Sheets: a Platform for Cardiac Regeneration "The state of the heart": Recent advances in engineering human cardiac tissue from pluripotent stem cells Generation and Assessment of Functional Biomaterial Scaffolds for Applications in Cardiovascular Tissue Engineering and Regenerative Medicine Modeling structural and functional deficiencies of RBM20 familial dilated cardiomyopathy using human induced pluripotent stem cells Bioengineering Human Myocardium on Native Extracellular Matrix.Thymosin β4 Improves Differentiation and Vascularization of EHTs.Obtaining spontaneously beating cardiomyocyte-like cells from adipose-derived stromal vascular fractions cultured on enzyme-crosslinked gelatin hydrogels.Three-Dimensional Human Cardiac Tissue Engineered by Centrifugation of Stacked Cell Sheets and Cross-Sectional Observation of Its Synchronous Beatings by Optical Coherence Tomography.Impact of Cell Composition and Geometry on Human Induced Pluripotent Stem Cells-Derived Engineered Cardiac Tissue.Mitochondrial respiratory dysfunction disturbs neuronal and cardiac lineage commitment of human iPSCs.Current Strategies and Challenges for Purification of Cardiomyocytes Derived from Human Pluripotent Stem Cells.Functional Effects of a Tissue-Engineered Cardiac Patch From Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in a Rat Infarct Model.Teratocarcinomas Arising from Allogeneic Induced Pluripotent Stem Cell-Derived Cardiac Tissue Constructs Provoked Host Immune Rejection in Mice.Design Principles for Engineering of Tissues from Human Pluripotent Stem Cells.Preclinical study of mouse pluripotent parthenogenetic embryonic stem cell derivatives for the construction of tissue-engineered skin equivalent.Reprogramming-derived gene cocktail increases cardiomyocyte proliferation for heart regeneration.Differentiation of pluripotent stem cells into endothelial cells.A Novel Probe as Surface Glycan Marker of Pluripotent Stem Cells: Research Outcomes and Application to Regenerative Medicine.Stem cell-derived vasculature: A potent and multidimensional technology for basic research, disease modeling, and tissue engineering.Modeling Alzheimer's disease with human induced pluripotent stem (iPS) cells.Stem cell-derived cell-sheets for connective tissue engineering.Human Engineered Heart Muscles Engraft and Survive Long Term in a Rodent Myocardial Infarction Model.The Future of Cardiovascular Regenerative Medicine.Striated muscle function, regeneration, and repair Progress in Corneal Stromal Repair: From Tissue Grafts and Biomaterials to Modular Supramolecular Tissue-Like Assemblies.Recreating the Cardiac Microenvironment in Pluripotent Stem Cell Models of Human Physiology and Disease.Surface-modified polymers for cardiac tissue engineering.Purification of small molecule-induced cardiomyocytes from human induced pluripotent stem cells using a reporter system.NK Cell Alloreactivity against KIR-Ligand-Mismatched HLA-Haploidentical Tissue Derived from HLA Haplotype-Homozygous iPSCs MiR30-GALNT1/2 Axis-Mediated Glycosylation Contributes to the Increased Secretion of Inactive Human Prohormone for Brain Natriuretic Peptide (proBNP) From Failing Hearts.Changes of plasmalogen phospholipid levels during differentiation of induced pluripotent stem cells 409B2 to endothelial phenotype cells.Three-Dimensional Adult Cardiac Extracellular Matrix Promotes Maturation of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.Untiring steps toward the maturation of human stem cell-engineered heart tissue.RETRACTED: In Vitro Modeling of Blood-Brain Barrier with Human iPSC-Derived Endothelial Cells, Pericytes, Neurons, and Astrocytes via Notch Signaling

P2860

Q26765916-B42F2D25-DDD0-42D0-BC61-CCB27B790EA9 Q27022144-0828D365-E86A-4D80-ADFB-1BFDB08247CB Q27320200-180ED8EB-D5C7-4A65-BBAE-8A1582BBA2C1 Q27325259-9A53D08D-FB37-4564-96E9-71568BA5DB06 Q27330969-16B51639-C8AA-478B-9B7B-B6319223FC99 Q28068965-A340581E-3ADA-416D-B134-5F67F56F2DCD Q28077395-D8CC0ACC-29B3-4D9E-B726-90ADD729E182 Q28084360-588EE1E6-7A11-4E61-AACC-5E8ED09E9EC2 Q30390768-8F19E037-F46C-4620-A0BD-29E6FEF55A1A Q30696630-1638E6E9-4E8C-4F89-8A1F-37ACAD83DF41 Q30706278-A5607FC5-2ED0-4B7F-9029-1119F9B05868 Q30836792-2AE45B5D-1AA7-4036-99CA-793980C073D1 Q30837375-DFE27232-B113-4016-8826-1947BA048270 Q30841190-34D6A256-8CC1-46C2-9EE9-9BB520F2F4AD Q30843677-6FC88907-7C63-4DAA-8254-BC5BC21B6669 Q30844772-DEE24FFD-F416-45CD-84D4-0A3E7FC0F3EA Q33821060-45EE49D9-E16C-4831-A6D2-E85A1AE0006D Q36212655-DDEBC97D-256B-43A6-B7FA-0A92347FCED5 Q36499442-33C9936B-D948-4120-BB85-669FAA11C0DF Q37012262-11A09560-0BBE-4E0A-969B-AA43A684D33D Q37358913-29CC93A6-D440-45E7-8381-153EAF3A277F Q37617991-3F826908-FAA2-42CC-A4C1-B451775049DF Q38376496-FE203113-6BAD-420A-8E0D-687F3532719E Q38420482-C07923E3-4459-47AB-B73B-B128B6D0A1A4 Q38597068-61551F62-5A40-49FE-AC98-BAF217EC53BB Q38666481-F279B9EF-78AF-4025-8123-C6EFCE9063AA Q38799501-5DADE19B-0C99-49D5-835F-F3AECB33D4C7 Q38842308-4DD50E50-214A-44EF-9349-AFCE90FFF756 Q38850633-63C0B79B-EA98-4AD7-B110-2AAE1060D63B Q38857890-9F1FEB76-73C0-4EE6-9A65-A149645AF306 Q38888357-8C7B1EBE-DCB8-4EC4-B7D5-12F7BE36E20B Q39050847-EA9C9F71-58F5-410B-90FB-272468350D8C Q40083319-9CDE587F-60AD-4893-A2B3-DB43922BA2AF Q40381516-4A6CE99B-EF6E-4CD9-BE81-78CC04B68216 Q41062471-1FB407A6-0C5A-4607-8DDF-CC79F77CC49E Q41102306-F5CE8F86-5563-4502-A7BF-468FA1C9152B Q41517954-B43F4A7F-02A8-48BA-A99C-29D9960951CB Q41528472-1EFE8FCB-888C-43A1-BAEA-A3B1FA3E42A6 Q42106737-37D7E5F2-C634-4DD1-9FE2-797476A1D52B Q42244735-40070531-57FB-447F-AD03-CD8443EA1AA4

P2860

Human iPS cell-engineered cardiac tissue sheets with cardiomyocytes and vascular cells for cardiac regeneration.

http://www.wikidata.org/entity/Q30594949

description

2014 nî lūn-bûn

@nan

2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Human iPS cell-engineered card ...... ells for cardiac regeneration.

@ast

Human iPS cell-engineered card ...... ells for cardiac regeneration.

@en

type

label

Human iPS cell-engineered card ...... ells for cardiac regeneration.

@ast

Human iPS cell-engineered card ...... ells for cardiac regeneration.

@en

prefLabel

Human iPS cell-engineered card ...... ells for cardiac regeneration.

@ast

Human iPS cell-engineered card ...... ells for cardiac regeneration.

@en

P1433

Q30594949-96FA7F2A-31C9-40EE-85A8-4D6E98F7B369

P1476

Q30594949-10300AC6-83DA-45C6-926C-FE1EF15CE1F4

P2093

Q30594949-499DA3E0-182A-49C1-A9EF-1372499859DE

Q30594949-5B83D4DA-0E01-49F9-9BF3-4D5CC8227B2F

Q30594949-A66D8AFE-D6F8-45D0-AB17-8378206B31E9

Q30594949-B55A1623-1059-49CA-B354-4A508D7B1588

Q30594949-B97D79DD-40E0-470B-9022-4DD115D0EE16

Q30594949-CDF2DFE4-DFBC-47BF-9D09-36FF21408740

Q30594949-D7324D96-B424-4AB1-BC68-ABD3E6C8044D

Q30594949-DDAE5198-AB4D-4749-8137-5BF901168942

Q30594949-EDCCE5F8-7621-402B-B75D-B19A70B1CF76

Q30594949-EFE7B86F-A2FC-4297-8758-337944066EDE

P2860

Q30594949-03D79251-E6EF-478A-BC1D-70E0E3CC443A

Q30594949-07E9415F-6A0C-4FAB-8EB6-B5089BD11563

Q30594949-0B46E468-5470-496B-9A0A-70EB06DCDD51

Q30594949-1D9B734C-9D6E-43C3-9C49-E80F821DB063

Q30594949-2AA7A059-AF9C-4280-BAF5-B5D126517C54

Q30594949-2E53DF0A-7FCE-4B11-BD30-7139B0CBDB6C

Q30594949-32189987-190F-4F22-8683-3670141A5E21

Q30594949-4C0FE724-1442-4190-8811-3FD39676FF54

Q30594949-54F67BF9-0729-4962-9EB4-8473BBA91180

Q30594949-653EB390-3E3B-442E-9D0E-D2B6FA4FB22F

P2888

Q30594949-0798EDCE-A4A7-4A27-9747-87468CB85EA8

P304

Q30594949-37F8A4FF-651A-4A35-9434-B543C0FBFD30

P31

Q30594949-1F3D9625-2CF4-487F-87CB-467F053AA08A

P356

Q30594949-B3F7D035-A809-45D1-8CFA-30BF29AABB0F

P407

Q30594949-962C154E-4039-4008-AC72-F9B696D713B9

P478

Q30594949-14784E9A-A348-4C17-86B9-7A0B26F27036

P577

Q30594949-662FB7C8-0FCA-4965-8FE3-2FFE3B7EFD93

P5875

Q30594949-EEE090B2-6B41-4738-A570-2E5CB93C1344

P6179

Q30594949-9F2DFD54-D202-46A7-B180-37EFBE1D2C35

P698

Q30594949-F2EEC99B-C8A0-4702-BDD7-25EFD354F863

P932

Q30594949-75DD8B5D-A4E5-4752-BA75-928C1B9C3E52

P356

P1433

Scientific Reports

P1476

Human iPS cell-engineered card ...... ells for cardiac regeneration.

@en

P2093

Akira Marui

http://www.w3.org/2001/XMLSchema#string

Hidetoshi Masumoto

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Fukushima

http://www.w3.org/2001/XMLSchema#string

Jun K Yamashita

http://www.w3.org/2001/XMLSchema#string

Masafumi Takeda

http://www.w3.org/2001/XMLSchema#string

Ryuzo Sakata

http://www.w3.org/2001/XMLSchema#string

Shiori Katayama

http://www.w3.org/2001/XMLSchema#string

Tadashi Ikeda

http://www.w3.org/2001/XMLSchema#string

Takeshi Ikuno

http://www.w3.org/2001/XMLSchema#string

Tatsuya Shimizu

http://www.w3.org/2001/XMLSchema#string

P2860

Efficient and scalable purification of cardiomyocytes from human embryonic and induced pluripotent stem cells by VCAM1 surface expression

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

Embryonic stem cell lines derived from human blastocysts

A more efficient method to generate integration-free human iPS cells

Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts

Proangiogenic scaffolds as functional templates for cardiac tissue engineering.

In vitro engineering of vascularized tissue surrogates.

Differentiation-defective phenotypes revealed by large-scale analyses of human pluripotent stem cells.

Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium.

Regenerating new heart with stem cells.

P2888

P304

6716

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP06716

http://www.w3.org/2001/XMLSchema#string

P407

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2014-10-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

267740977

http://www.w3.org/2001/XMLSchema#string

P6179

1029962561

http://www.w3.org/2001/XMLSchema#string

P698

25336194

http://www.w3.org/2001/XMLSchema#string

P932

4205838

http://www.w3.org/2001/XMLSchema#string